Effective methylprednisolone "pulse" therapy in myeloerythroid aplasia associated with systemic lupus erythematosus: case report and literature review.
We report a rare case of myeloerythroid aplasia associated with systemic lupus erythematosus (SLE). The erythroid aplasia was completely reversed after treatment with 60 mg of prednisolone daily, but methylprednisolone "pulse" therapy was necessary to improve the myeloid aplasia.
Yamauchi
K
K
Department of Internal Medicine, School of Medicine, Tokai University, Kanagawa, Japan.
Arimori
S
S
D000328:Adult; D000380:Agranulocytosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008775:Methylprednisolone / Q000008:administration & dosage*; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000209:etiology
D007074:Immunoglobulin G; D008775:Methylprednisolone